7/8/2021CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...

7/8/2021CDE Solicits Comments on the Technical Guidelines for Pharmacokinetic ...

7/8/2021CDE Solicits Comments on the Guidelines for Clinical Research of Late ...

7/8/2021CDE Solicits Comments on the Technical Guidelines for Writing Safety R...

7/8/2021Sparx Therapeutics to Build Its First ADC Production Facility in Yangz...

7/8/2021BeiGene/Amgen Wins Chinese Approval of KYPROLIS (Crfilzomib) for r/r M...

7/8/2021China Passes Data Security Law to Take Effect in Less Than Two Months

7/8/2021Revision of China's Anti-Monopoly Law to Close "Loopholes" in Anti-car...

7/8/2021Ex-Genentech Staffers Plead Guilty To Trade Secrets Theft as DOJ Targe...

7/8/2021Is China's Drug Regulator Suddenly Raising the Bar on Cancer Med R&D? ...

7/7/2021Further Updates on Patent Linkage and Patent Term Extension in China

7/7/2021NMPA Re-elected as ICH Management Committee Member

7/7/2021Lippo Healthcare, AstraZeneca Pens Deal for Investment in China's Grea...

7/7/2021Neurolief Enters Licensing Deal with NeuroFront for Relivion in Greate...

7/7/2021dMed-Clinipace Completes US$50M Series C+ Financing

7/6/2021Alibaba Health-Backed LinkDoc Files for U.S. IPO

7/6/2021Antengene Granted Chinese IND Approval for Phase II Trial of Single-...

7/6/2021NMPA Announces Package Insert Revision of Metoclopramide Products

7/6/2021Innovent and Laekna Enter a Partnership to Co-Develop Combo of Sinti...

7/6/2021CStone Granted Chinese IND Approval for I/O Candidate CS2006/NM21-14...

7/6/2021Y-mAbs Submits Chinese BLA for DANYELZA® (naxitamab-gqgk)

7/5/2021GSK Launches HIV Drug Dovato (dolutegravir/lamivudine) in China

7/5/2021NMPA and CNIPA Issues the Implementation Measures for Early Resolution...

7/5/2021NMPA Issues Announcement Relating to the Implementation Measures for E...

7/5/2021Abbisko and Sperogenix Announce Deal of ABSK021 for ALS and Other Rare...

7/5/2021Nicox Amends Deal with Ocumension with $2M Upfront

7/5/2021Patent Linkage Implementing Measures Came Into Force in China on July ...

7/2/2021At A Glance: Pharmaceutical Merger Review in China

7/2/2021NDRC Issues the Implementation Plan for Infrastructural Building of th...

7/2/2021CDE Solicits Comments on the Requirements for Pharmaceutical Common Qu...

Page:124/719 Total number of articles:21549: [First][<<] [122] [123] [124] [125] [126] [>>] [End]